Hologic Lawsuit: The Data Breach Case Was Dropped, BioZorb Settled
Case Dismissed
Claim deadline is October 15, 2026 · as of Oct 15, 2026
There is no open Hologic class action settlement, no claim form and no deadline as of October 15, 2026. The data breach class action filed in Boston on July 8, 2026 was voluntarily dismissed on August 12, 2026. The BioZorb breast-marker injury cases were resolved by a private settlement signed January 7, 2026. A new hacker claim from September 7, 2026 has not been confirmed by Hologic and has not produced a lawsuit.
Questions about this case?
AI Legal Assistant · free · answers in seconds · general information, not legal advice
Independent information service: Settlement Insight is not the settlement administrator, is not affiliated with or endorsed by the company named above, and is not a law firm. Submitting this form does not file a claim — it shares your information with our participating legal intake partners, who may contact you about your options.
Can I Still File?
The claim deadline, what the settlement pays and where to file — plus other settlements still taking claims.
No. The claim deadline was October 15, 2026.
Other settlements with open claim windows
- Gabapentin Lawsuit$533M · claim by November 9, 2026
- RealPage Settlement$359.9 million · claim by January 29, 2027
- RealPage Payout Date$359.9M · claim by January 29, 2027
We are not a claims administrator and not affiliated with any settlement. File only at the official settlement website — filing is always free.
What the Hologic Lawsuits Are About
Hologic is a women’s-health medical technology company in Marlborough, Massachusetts — mammography, biopsy devices, lab tests. Three groups of cases carry its name.
The data breach suit. A proposed class action filed July 8, 2026 alleged that sensitive personal data Hologic held was exposed in a cyberattack, which Law360 described as a ransomware attack. Hologic has not publicly confirmed a breach, and it is not clear which incident the suit concerned: ransomware groups posted claims about Hologic on February 4 and June 28, 2026, the second asserting 98 GB of stolen data — an attacker’s claim, not a verified figure.
The BioZorb cases. About 200 people sued over the BioZorb 3D marker, an implant placed during lumpectomy surgery. The suits alleged side effects not disclosed in the instructions for use — the device failing to dissolve, migrating, eroding, pain and infections — and problems with its design, manufacture and marketing.
The merger suits. Shareholders sued in January 2026 over the disclosures for Hologic’s sale to Blackstone and TPG.
Case details
Data breach: Cameron v. Hologic, Inc., No. 1:26-cv-13147, U.S. District Court for the District of Massachusetts, assigned to Judge Donald L. Cabell. Hologic was served July 23, 2026, with an answer due August 13, 2026. On August 12, 2026 the plaintiff filed a notice of voluntary dismissal without prejudice under Rule 41(a)(1)(A)(i); the case closed August 13, 2026.
BioZorb: the federal cases were in the same court before Judge Allison Burroughs; one of the federal dockets is Chambers v. Hologic, Inc., No. 1:23-cv-10260. One case was in Massachusetts state court, where the first complaint was filed November 4, 2022.
Merger: Southfield Fire & Police Retirement System v. Hologic, No. 2026-0060-BWD (Delaware Chancery, January 14, 2026), plus two New York state cases, Nos. 650252/2026 and 650272/2026. The deal closed April 7, 2026; Hologic is now private and its stock was delisted.
Status: Nothing Open to Claim
Data breach — dismissed. The only filed data breach class action ended by voluntary dismissal on August 12, 2026, about five weeks after filing and before Hologic’s answer was due. No class was certified and no settlement was reported. Because the dismissal was without prejudice, the claims could be refiled; we found no refiled case.
BioZorb — settled privately. Hologic says it signed a settlement agreement on January 7, 2026, with no admission of liability and fully covered by insurance. It is not a class settlement: it covers people who had already sued, and it depended on a participation threshold. Terms were not disclosed.
New hacker claim — unconfirmed. A group posted on September 7, 2026 that it had attacked Hologic. As of mid-October 2026 there is no notice letter, no confirmed data list and no lawsuit tied to it — only law firms advertising investigations.
Who Could Be Affected
Data breach: the dismissed suit proposed a class of people whose data Hologic held. Since no breach has been confirmed publicly, the real test is a written notice letter from Hologic. If you received one, keep it and the envelope. If you did not, there is nothing to join — no class exists.
BioZorb: the settlement covered people who had filed their own lawsuits. The FDA counts 53,492 BioZorb markers recalled in the U.S., distributed April 29, 2019 to April 1, 2024. Having one implanted does not make you part of the settlement. The FDA says there is no need to have the marker removed unless your doctor advises it.
Former shareholders: the merger suits were about proxy disclosures, not a payout to consumers.
Is There Money, and How Much
BioZorb: amounts undisclosed. Hologic reports the settlement amount is fully covered by insurance and that it expects no financial liability; individual amounts were not made public. There is no public claim form.
Shareholders: the deal paid $76 per share in cash plus a contingent value right of up to $3 (two payments of up to $1.50), tied to Breast Health revenue goals for fiscal 2026 and 2027.
How cases like this one end
Our copy of the federal courts’ own case database covers 16,001 other personal property damage casesclosed in U.S. federal district courts between 2015 and 2026, 11.3% of them filed as class actions:
- 32.5% ended in a settlement recorded by the court. Another 19.5% were dismissed voluntarily, which often follows a private settlement — so the real settlement share sits between 32.5% and 52.1%.
- 5.9% were decided on a motion before any trial.
- 1 in 90 reached a trial (1.1%), after a median of 27.5 months.
- Median time from filing to the end of the case: 8.4 months.
- Only 250 of them (1.6%) record a money award at all; the median of those is $443,000.
These are base rates for this type of case (federal other personal property damage cases) — not a prediction about this lawsuit, and not legal advice. Source: Federal Judicial Center, Integrated Database (civil), analysed by Settlement Insight. Cases heard in state courts are not included.
Hologic Lawsuit Timeline
November 4, 2022 — First BioZorb Complaint
A product liability suit is filed in Massachusetts state court; about 200 plaintiffs eventually sue, mostly in federal court in Boston.
October 25, 2024 — FDA: Do Not Use BioZorb
Hologic recalls all unused BioZorb markers and the FDA tells providers not to implant them. The earlier March 2024 correction is a Class I recall.
January 7, 2026 — BioZorb Settlement Signed
Hologic executes a settlement agreement with no admission of liability, fully covered by insurance. Terms are not disclosed.
July 8, 2026 — Data Breach Class Action Filed
Cameron v. Hologic, No. 1:26-cv-13147, is filed in the District of Massachusetts, alleging personal data was exposed in a cyberattack.
August 12, 2026 — Data Breach Suit Dismissed
The plaintiff voluntarily dismisses the case without prejudice, one day before Hologic’s answer was due. The docket closes August 13, 2026.
September 7, 2026 — New Hacker Claim, No Lawsuit
A ransomware group claims an attack on Hologic. As of October 15, 2026 Hologic has not confirmed it and no suit has been filed over it.
Three Things to Watch For
Unconfirmed hacker claims and a dropped lawsuit leave room for confusion that imposters use:
“Claim your Hologic data breach payment”
There is no Hologic breach settlement and no administrator. A site asking for your Social Security number or bank details to “register” for one is collecting data, not filing a claim.
Calls about your mammogram or biopsy records
If stolen data is real, scammers may cite your provider or test to sound credible. Hologic’s recall contact is breasthealth.support@hologic.com; do not give personal details to an unsolicited caller.
“BioZorb settlement still open — sign up today”
The BioZorb settlement covered people who had already sued, and law-firm sites report new cases are no longer being reviewed. An ad promising a share of it to anyone with a marker is misleading.
Hologic Lawsuit — Questions People Actually Ask
Short answers to the questions people ask most about this case.
Is there a Hologic data breach class action settlement?
No. The only filed case, Cameron v. Hologic (No. 1:26-cv-13147, D. Mass.), was voluntarily dismissed without prejudice on August 12, 2026. There is no settlement, no claim form and no deadline as of October 15, 2026.
Did Hologic have a data breach?
Hologic has not publicly confirmed one. Ransomware groups claimed attacks on February 4, June 28 and September 7, 2026; those are attacker claims. A notice letter from Hologic is the only reliable sign that your data was involved.
What was the BioZorb lawsuit about?
About 200 patients alleged that the BioZorb 3D marker, implanted during lumpectomy, caused undisclosed side effects such as failing to dissolve, migration, pain and infection. Hologic signed a settlement on January 7, 2026, without admitting liability.
Can I still join the BioZorb settlement?
There is no public claim form. The settlement covered people with pending lawsuits, and its terms were not disclosed. If you have a BioZorb marker and problems, talk to your doctor; whether you can still bring your own claim depends on your state’s deadlines, which a licensed attorney can assess.
Do I need to have my BioZorb marker removed?
Not automatically. The FDA’s October 25, 2024 safety communication says there is no need to have it removed unless your health care provider advises it, and asks patients to report complications to the FDA.
Is there currently a class action lawsuit against breast implants?
That is a separate matter. The FDA describes BioZorb as a radiographic marker, not indicated to fill space or improve cosmetic outcomes — it is not a breast implant. For breast implant illness and textured-implant cases, see our breast implant lawsuit page.
What is the Hologic stop ship about?
In November 2025 Hologic stopped shipping its Brevera Breast Biopsy System 9 Gauge Needles and later started a voluntary recall in consultation with the FDA. We found no lawsuit or settlement tied to it as of October 2026.
I owned Hologic stock. Is there a lawsuit for me?
Shareholders sued in January 2026 claiming the merger proxy left out material information, including No. 2026-0060-BWD in Delaware Chancery. Hologic called the claims without merit but supplemented its disclosures. The take-private closed April 7, 2026 at $76 per share plus a contingent value right of up to $3.
About This Information
- Editorially Reviewed — Content reviewed for accuracy using published legal research, government data, and verified court records. See our methodology. Reviewed by Leonard Goldberg, Editor · Last updated
- $236 billion in real payouts analyzed · See what we found
This page is for general information only and is not legal advice. Lawsuit status, eligibility, and compensation can change. Settlement Insight is not a law firm and does not represent any party. Consult a licensed attorney about your specific situation.
Related Consumer Brand Lawsuits
Other cases and free tools — not about this case.
Similar cases we track
- Breast Implant LawsuitsImplant illness and textured-implant cases, which BioZorb is not
- Open Class Action SettlementsSettlements that are taking claims right now, with deadlines
- Data Breach Settlement CalculatorWhat comparable breach settlements have paid per person
- Settlement Payout CalculatorEstimate a class action payout from fund size and claim rate